The US Department of Health and Human Services has launched a public consultation on the classification of vaccine recommendations, seeking to enhance communication and align with international best practices amid ongoing vaccine policy scrutiny.
The US Department of Health and Human Services has opened a public consultation on whether the labels used to describe federal vaccine recommendations still serve clinicians, patients and parents well, a move that could affect how immunisations are presented on national schedules.
In a request for information filed for public inspection on Friday and published in the Federal Register on Monday, the department asked whether the existing three-part framework of routine, risk-based and shared clinical decision-making is clear, adequate and widely understood. According to HHS, officials are also considering whether new categories should be created or existing ones reworked.
The consultation closes on September 20, 2026. HHS said it wants feedback on how the current system is used in practice and whether changes could improve communication around vaccine guidance. Shared clinical decision-making, one of the existing categories, is used when vaccination decisions are meant to be made jointly by a patient and clinician rather than treated as universal or limited to higher-risk groups.
The review comes against a broader backdrop of federal scrutiny of vaccine policy. In May, President Donald Trump signed an executive order directing HHS and the Centers for Disease Control and Prevention to examine childhood vaccine recommendations alongside those of peer developed countries. The White House said the aim was to align the US schedule with best practices from abroad, while an HHS assessment published around the same time called for updates to the core childhood and adolescent immunisation schedule.
HHS has said its National Vaccine Programme, backed by the National Vaccine Advisory Committee, is intended to provide strategic leadership and coordination on immunisation policy across federal agencies. The latest consultation suggests the administration is now looking not only at what vaccines are recommended, but also at how those recommendations are classified and explained to the public.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
